Ignite Creation Date:
2024-05-06 @ 2:48 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04424966
Status:
TERMINATED
Last Update Posted:
2024-03-27
First Post:
2020-05-27
Brief Title:
Infigratinib in Recurrent High-Grade Glioma Patients
Sponsor:
Nader Sanai
Organization:
St Josephs Hospital and Medical Center Phoenix
Organization Data
Organization:
St Josephs Hospital and Medical Center Phoenix
Class:
OTHER
Study ID:
2020-08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nader Sanai
Lead Sponsor Class:
OTHER
Responsible Party:
Nader Sanai
Responsible Party Title:
Deputy Director Ivy Brain Tumor Center
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
St Josephs Hospital and Medical Center Phoenix
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| QED Therapeutics | UNKNOWN |
| Ivy Brain Tumor Center | OTHER |
| Barrow Neurological Institute | OTHER |